Rx Machina: How AI is transforming pharma sales
Pharmaceutical Technology
JULY 31, 2023
Pharma sales have undergone a seismic transformation after Covid-19, with the adoption of artificial intelligence tools.
July, 2023
98 
A pharma banking on the success of past blockbusters
PharmaVoice
JULY 31, 2023
180 Life Sciences is on a mission to see if the anti-TNF technology that produced a blockbuster could work for a range of other conditions.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing
PharmExec
JULY 10, 2023
Join five industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.
Opinion: Why the aspartame in Diet Coke and Coke Zero probably isn’t worth worrying about
STAT
JULY 8, 2023
This essay was originally published on Gideon Meyerowitz-Katz’s Medium blog. A spartame is an artificial sweetener that is used in a lot of products, including Diet Coke and Coke Zero. Like most artificial sweeteners, we have a wonderful love/hate relationship with it. It’s sweet but doesn’t have any calories, so it’s great for people who want to lose a bit of weight.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
DigitalHealth.London’s Accelerator programme selects Aide
Pharma Times
JULY 3, 2023
Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes
Pfizer backs CRISPR biotech Caribou in latest cell therapy investment
BioPharma Dive
JULY 6, 2023
Five years after helping launch Allogene Therapeutics, Pfizer is backing another developer of “off-the-shelf” cell therapies in a deal that gives the drugmaker the chance to acquire a multiple myeloma treatment.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
Following FDA’s full approval of Leqembi, here’s what else is in the Alzheimer’s pipeline
PharmaVoice
JULY 7, 2023
Leqembi’s U.S. approval is a milestone in Alzheimer’s research and medicine — and there are a few other late-stage biologic drugs that could follow.
ISO publishes standard on bacterial endotoxin testing
European Pharmaceutical Review
JULY 4, 2023
The International Organization for Standardization (ISO) has published its new standard Sterilization of health care products — Microbiological methods — Part 3 Bacterial endotoxin testing ( ISO 11737-3:2023). The document contains requirements and guidance for testing for bacterial endotoxins. This includes products that must be non-pyrogenic based on either intended use or non-pyrogenic label claim, or both.
Most ambulances ‘run hot’ with lights and sirens blaring. But that’s starting to change
STAT
JULY 7, 2023
Jonathan Studnek knows some people imagine that driving an ambulance at high speed with lights flashing and sirens wailing — racing through messily parted traffic to the scene of a crisis — is the best part of being an emergency medic. For him, that couldn’t be further from the truth. “If you’ve been in the industry for any length, you know innately: When you’re in the front of an ambulance and the lights are on, that’s the most dangerous situatio
Digital health tech: a solution to substance use disorders?
Pharmaceutical Technology
JULY 4, 2023
Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
With new data, J&J steps forward in growing race for oral autoimmune drugs
BioPharma Dive
JULY 5, 2023
Phase 2 results show a pill the company is developing is competitive with other oral medicines in testing against psoriasis, among them the TYK2 inhibitors that have drawn significant industry interest.
Health Equity in Pharma: Communities Most Impacted by Racial Bias
PharmExec
JULY 5, 2023
Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.
With the neuro tide rising, could a breakthrough for Parkinson’s be next?
PharmaVoice
JULY 24, 2023
Amid a wave of neuro R&D, scientists are taking an Alzheimer’s-like approach to developing the first disease-modifying treatments for Parkinson’s.
Episode 831: What is the role for ketamine in refractory status epilepticus?
Pharmacy Joe
JULY 1, 2023
In this episode, I’ll discuss the role for ketamine in status epilepticus. Episode 831: What is the role for ketamine in refractory status epilepticus? Subscribe on iTunes , Android , or Stitcher The initial therapy for status epilepticus is to use one of the following benzodiazepines: Lorazepam 0.1 mg/kg capped at 4 mg IV Midazolam 0.2 mg/kg capped at 10 mg IM Diazepam 0.15 mg/kg capped at 10 mg IV But what happens if the patient does not respond to this initial therapy?
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
What the end of affirmative action means to a fourth-year medical student
STAT
JULY 3, 2023
When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.
Women in Science: How Charco Neurotech's Lucy Jung is 'restoring joy' for Parkinson's patients
Outsourcing Pharma
JULY 5, 2023
Lucy Jung is the CEO and founder at Charco Neurotech, a medtech start-up which has developed the CEU1, a non-invasive wearable device for Parkinson's, that uses vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement. We spoke to her about her background, how she got involved in the Parkinson's space and her fascination for problem-solving.
FDA releases analysis on drug product quality in 2022
European Pharmaceutical Review
JULY 3, 2023
The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. US drug product quality: drug recalls in FY2022 During the 2022 financial year, 166 manufacturing sites generated 912 drug recalls, the highest number of recalls in five years, according to the data.
Eli Lilly’s retatrutide sets new record for weight loss in obesity space
Pharmaceutical Technology
JULY 3, 2023
Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA’s upcoming psychedelic review looms large for a budding industry
PharmaVoice
JULY 12, 2023
A new psychedelic guidance from the agency gives a clue into how it could analyze drugs in the space, but industry leaders are eager for more.
Toxic Leadership in Healthcare
The Honest Apothecary
JULY 4, 2023
Jeremy, an HR business partner to the nursing staff of a medium sized community hospital, arrived at his desk at 8:30am on Monday to a familiar sight. There, sitting on his desk, was yet another resignation letter from a nurse on the 7th floor. Tina’s floor. Over the past 6 months Jeremy had 5 such letters reach his desk. Each one a subtle reminder to him that his organization is dealing face-to-face with the problem with toxic leadership in healthcare. “I regret to inform you that m
STAT+: Novo Nordisk bought prescribers over 450,000 meals and snacks to promote drugs like Ozempic
STAT
JULY 5, 2023
WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs. The pharmaceutical company bought more than 457,000 meals to educate doctors and other prescribers about its portfolio of drugs known as GLP-1 agonists, according to the newly released data from the Centers for Medicare and Medicaid Services.
European regulators probe suicide risk to Ozempic, other Novo drug Saxenda
BioPharma Dive
JULY 10, 2023
Three reports from Iceland spurred the EMA to evaluate whether certain Novo Nordisk drugs, including Ozempic, might cause thoughts of self harm.
Enhance Healthcare Efficiency With Top Payroll & HCM Services
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Innovation key for boosting UK biopharma competitiveness
European Pharmaceutical Review
JULY 7, 2023
New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.
Complex road ahead, despite phase 3 progress, for Annovis’ buntanetap in Parkinson’s Disease
Outsourcing Pharma
JULY 4, 2023
Drugs like Annovis Bioâs buntanetap and prasinezumab have the potential to ârevolutionize the treatment of Parkinsonâs Diseaseâ says analytics company, GlobalData, an analytics company, but it is a complex road ahead.
Threads joins the social media fray. Here’s what it means for pharma marketers
PharmaVoice
JULY 18, 2023
Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.
Revealed: pharma giants pour millions of pounds into NHS to boost drug sales
The Guardian - Pharmaceutical Industry
JULY 8, 2023
Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products Pharmaceutical giants are pouring tens of millions of pounds into struggling NHS services – including paying the salaries of medical staff and funding the redesign of patient treatment – as they seek to boost drug sales in the UK, the Observer can reveal.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Why depression after traumatic brain injury is distinct — and less likely to respond to standard treatment
STAT
JULY 6, 2023
Traumatic brain injury multiplies the risk of major depression eightfold. While the emotional trauma of whatever caused such deep damage may be understandable, from a blast in a war zone to a blow on the playing field, there’s a physiological component, too, that neuroscientists have long suspected but have been unable to identify. “As clinicians, a lot of us had a gut feeling that [TBI-associated depression] is a different disease,” said Shan Siddiqi, a Harvard Medical Scho
Novartis buys a preclinical biotech and its RNA drug technology
BioPharma Dive
JULY 17, 2023
For $500 million, Novartis will acquire DTx Pharma and its preclinical neurological disease drugs, marking the Swiss company’s latest investment in gene-silencing medicines.
Strategies to Boost Your Pharmacy’s Front-of-House Sales
Digital Pharmacist
JULY 31, 2023
To boost your pharmacy’s storefront sales, the best place to start is by understanding the importance of pharmacy marketing and making sure you are taking the necessary steps to optimize your front-end sales. With the right strategies, you can increase customer loyalty, drive more sales, and establish yourself as a reliable pharmacy in your community.
CPHI South East Asia visitor numbers expected to double as interest in drug supply chain security booms
Outsourcing Pharma
JULY 6, 2023
This yearâs CPHI South East Asia is expecting a surge in international partnering with organizers expecting a record attendance of 8,000 visitors including a significant number from overseas â doubling last yearâs figures.
A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here
PharmaVoice
JULY 20, 2023
Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.
Let's personalize your content